GCC Healthcare Market: size, growth and outlook 2026–2032

The GCC healthcare market — public and private spending on hospitals, clinics, diagnostics and related services across Saudi Arabia, the UAE, Qatar, Kuwait, Oman and Bahrain — is one of the fastest-growing healthcare markets in the world relative to its population. Published estimates for 2025 range from USD 118 bn to USD 129 bn depending on whether pharmaceuticals, devices and insurance are counted alongside services; our central estimate is USD 121 bn, growing at about 7% a year to USD 194 bn by 2032.

Three forces drive the growth: population growth and ageing in a region where chronic disease prevalence (diabetes, cardiovascular, obesity) is among the highest globally; government programmes that shift delivery to the private sector while keeping the state as the dominant payer (Saudi Vision 2030 and the Health Sector Transformation Program; UAE mandatory insurance in Abu Dhabi, Dubai and now the northern emirates); and capacity expansion — thousands of new beds planned or under construction across the region, much of it private or PPP.

Saudi Arabia is the largest market by far, followed by the UAE; the two together account for roughly three-quarters of regional spend. For suppliers, the GCC is a high-price, high-specification, tender-driven market where registration, local distribution and insurer relationships decide access.

The chart shows the Consulting Wallah central estimate: published figures normalised to 2025, median taken, and projected at the median published growth rate. The published range for 2025 is USD 118 bn–USD 129 bn; differences are mostly scope.

Included: hospital and clinic services (inpatient, outpatient, day-care), diagnostics and laboratory services, long-term and home care, and the associated government and private health expenditure. Reported separately in our other reports: pharmaceuticals, medical devices, health insurance premiums and health IT. Some publishers fold these into "healthcare market" totals, which explains the wider range of published figures.

Segmentation: by country; by provider (public, private, PPP); by service type; by payer (government, insurance, out-of-pocket).

Shares as reported by the named sources; ranking is more reliable than the exact percentage.

• GCC CHE was 5.0% of GDP in 2024, projected to reach 5.7% by 2029 (Alpen Capital)
• GCC hospital bed density 20.8 beds per 10,000 population (end-2024), above the global average per GCC-Stat (Times of Oman / GCC-Stat)
• Government-owned beds account for 73% of GCC bed capacity (Times of Oman / GCC-Stat)
• Nursing staff make up 39.3% of the 1.05 million GCC healthcare workforce (Times of Oman / GCC-Stat)
• GCC saw 400+ healthcare M&A/investment transactions 2021-2025 (UAE 198, Saudi 170) (PharmaKnowl)
• GCC added 1,846 hospital beds 2020-2022 to reach 133,731 beds (Alpen Capital older edition) (AGBI)
• Frost & Sullivan expects ~30% of hospital investment to go to digital health infrastructure over the next decade (AGBI)
• Burjeel Holdings signed an MoU with Saudi Ministry of Investment to invest up to USD 1 bn in Saudi hospitals/clinics (Aug 2022); Burjeel then had 1,660 beds across UAE and Oman (Gulf News)
• PureHealth's Daman insured 3.4 million members with H1 2026 GWP of AED 5.5 bn (Khaleej Times)

Saudi Arabia

The Health Sector Transformation Program is corporatising public hospitals into regional health clusters, expanding private provision and PPP, and privatising non-core services. NUPCO centralises purchasing for the public sector; private groups (Dr Sulaiman Al Habib, Mouwasat, Dallah, Fakeeh, Al Hammadi) are listed and expanding. Giga-projects (NEOM, Red Sea, Qiddiya) carry health components.

UAE

Mandatory insurance (Abu Dhabi 2006, Dubai 2014, federal expansion from 2025) made private providers the majority of outpatient volume. Consolidation into large groups (PureHealth/SEHA, Burjeel, NMC, Mediclinic, Aster, Emirates Health Services) and specialist capacity (oncology, cardiac, paediatric) are the growth themes; Abu Dhabi and Dubai compete as medical-tourism hubs.

Qatar, Kuwait, Oman, Bahrain

Qatar is public-led (Hamad Medical Corporation) with growing private capacity; Kuwait is mid-way through a large public hospital build-out; Oman is opening the sector to private investment under Vision 2040; Bahrain has introduced a national health insurance scheme (Sehati).

Relevance for India

GCC hospital groups source clinicians, nurses, pharmaceuticals, consumables and increasingly devices from India; Indian hospital groups are entering the region (Aster, Apollo, Medanta partnerships). The two markets are linked by workforce, supply chain and patient flows.

Key companies named across the sources; local distributors and implementation partners matter as much as the brand in the GCC and India.

• Operators and investors: private capacity is still growing, but the easy outpatient growth is done in the UAE; the opportunities are specialist tertiary care, day surgery, home care, long-term care and Saudi secondary cities. Design central procurement and insurer contracting into the operating model from day one.
• Suppliers: registration (SFDA, MOHAP/DoH/DHA), a local partner and insurer-formulary presence are prerequisites; central tenders (NUPCO, SEHA/PureHealth, DHA) reward structured quotations and reliable supply over the lowest price.
• Hospital leaders: insurer price pressure and medical inflation make procurement and supply chain the margin lever; see our procurement advisory.

1. Arabian Business (Alpen Capital), GCC healthcare spending to hit $159bn by 2029 — arabianbusiness.com
2. Mediworld ME, Alpen Capital Forecasts Robust Growth for the GCC Healthcare Industry — mediworldme.com
3. BCC Research, Healthcare Innovation in the GCC — bccresearch.com
4. BCC Research blog, The Future of GCC Healthcare Driven by Growth and Innovation — blog.bccresearch.com
5. Times of Oman (GCC-Stat), Healthcare sector in GCC countries sees rapid expansion — timesofoman.com
6. PharmaKnowl, MedTech industry statistics in the Gulf markets (GCC) — pharmaknowl.com
7. AGBI, More GCC healthcare mergers likely as competition hots up — agbi.com
8. Khaleej Times, PureHealth reports H1 2026 results — khaleejtimes.com
9. Gulf Business, What's fueling the GCC's hospital bed boom? — gulfbusiness.com
10. Gulf News, UAE's Burjeel Holdings to spend $1b on hospitals, clinics in Saudi Arabia — gulfnews.com
11. Alpen Capital (GCC Healthcare Industry report, via Arabian Business) (2025-02) — USD 109.1 bn (current healthcare expenditure, CHE) (2024) to USD 159.0 bn (2029), CAGR 7.8%; scope: GCC current healthcare expenditure; CHE 5.0% of GDP (2024) rising to 5.7% (2029) — source
12. BCC Research (Healthcare Innovation in the GCC, HLC307A) (2025-07) — USD 121.9 bn (2024) to USD 170.5 bn (2030), CAGR 5.9% (2025-2030); scope: Total addressable healthcare market across 6 GCC states; Saudi Arabia to reach USD 86.8 bn by 2030 (4.6% CAGR) — source
13. Alpen Capital (earlier edition, via AGBI) (2023) — USD 104.1 bn (2022) to USD 135.5 bn (2027), CAGR 5.4%; scope: GCC healthcare spending; UAE + Saudi ~80% of regional spend by 2027 — source
14. Consulting Wallah Network — anonymised observations from procurement and business-setup work with hospital groups and suppliers in the UAE, India and Bangladesh (2024–26), used for the GCC/India outlook and the “what it means” section.
15. Method. Each published figure is normalised to a 2025 base using its own CAGR; the Consulting Wallah central estimate is the median of the normalised figures (or the stated scope where noted) projected at the median CAGR to 2032. Country figures are quoted as published; where we add a CW estimate it is labelled.